You are here

Health & well-being

The Health Sector Redefines Its Frontiers

Well-being, nutrition, security, ecosystems, interconnectedness...
Research at Grenoble Ecole de Management aims to provide insights into the latest evolutions in business and society.

Up until recently, the pharmaceutical industry was the primary focal point for the health sector. However, recent changes have created a new ecosystem where players such as telephone companies, food industrials, sports specialists and private insurance companies all have a role to play. Our researchers are working to understand the roles, hierarchies and business models created by this evolution.

Understanding a new ecosystem

Whether it's to upload data while jogging, use telemedicine services through our phone operators or reinvent preventive insurance coverage, many companies are exploring new ways to participate in and lead this health ecosystem.

Our researchers are studying this evolution in order to better understand topics such as how new ecosystems emerge, which players are leading the way, what new business models are being created, and what strategies are being implemented to gain market shares.


Chair Public in Trust : highlights 2017 and outlook 2018

20 March 2018
The Chair for Public Trust in Health at GEM was inaugurated in September 2017. It is funded by Fondation Grenoble Ecolede Management, School for Business and for Society, in partnership with Bristol-Myers Squibb France, with the goal of better understanding the drivers of and challenges surrounding collective trust in the health field.

Research: Health Industry, Technological Innovation Tied to Business Model Innovation

31 March 2017
Health Industry, Technological Innovation Tied to Business Model Innovation
With the growth of digital tools and applications, many industries are faced with the arrival of new players. This latest study explores the use of applications in the healthcare industry in order to better compare the innovation capacity between incumbent industry companies such as pharmaceutical companies and newcomers such as digital tech companies. This article from Janna Rose, Vincent Mangematin and Yi Jiang is the subject of the 34th Grenoble Ecole de Management Executive Summaries.